[Federal Register Volume 75, Number 177 (Tuesday, September 14, 2010)]
[Notices]
[Pages 55831-55832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22827]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the patients' rights advocate position on the 
Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees 
should have professional or personal experience with or knowledge about 
patient advocacy. Also, involvement or leadership with patient advocacy 
organizations is preferred.

DATES: Nominations are due on or before November 15, 2010.

NOMINATION PROCESS:  Submit an electronic copy of resume or curriculum 
vitae, along with a cover letter, to Ms. Ashley Cockerham, 
[email protected]. The cover letter should describe the 
nominee's current involvement with patients' rights advocacy and 
express the nominee's interest in the position. Please ensure that 
resume or curriculum vitae includes the following information, if 
applicable: education; certification; professional association 
membership and committee membership activities; and number of years, 
recentness, and type of setting for patient advocacy.

FOR FURTHER INFORMATION CONTACT: Ms. Ashley Cockerham, U.S. Nuclear 
Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs; (240) 888-7129; 
[email protected].

SUPPLEMENTARY INFORMATION: The patients' rights advocate provides 
advice to NRC staff on patients' issues associated with the regulation 
of medical applications of byproduct material. This advice includes 
ensuring patients' rights are represented during the development and 
implementation of NRC medical-use policy. This individual is appointed 
based on his or her professional and personal experience with and/or 
knowledge about patient advocacy, involvement and/or leadership with 
patient advocacy organizations, and other information obtained in 
letters or during the selection process. Nominees should have the 
demonstrated ability to establish effective work relationships with 
peers and implement successful approaches to problem solving and 
conflict resolution. ACMUI members currently serve a four-year term and 
may be considered for reappointment to an additional term. The current 
membership is comprised of the following professionals: (a) Nuclear 
medicine physician; (b) nuclear cardiologist; (c) nuclear medicine 
physicist; (d) therapy medical physicist; (e) radiation safety officer; 
(f) nuclear pharmacist; (g) two radiation oncologists; (h) patients' 
rights advocate; (i) Food and Drug Administration representative; (j) 
Agreement State representative; (k) health care administrator; and (l) 
diagnostic radiologist. For additional information about membership on 
the ACMUI, visit the ACMUI Membership Web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members are expected to 
attend semi-annual meetings in Rockville, Maryland and to participate 
in teleconferences, as needed. Members who are not Federal employees 
are compensated for their service. In addition, these members are 
reimbursed for travel and correspondence expenses. Full-time Federal 
employees are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a

[[Page 55832]]

thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to assure that there are no 
conflicts of interest.

    Dated at Rockville, Maryland this 8th day of September, 2010.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2010-22827 Filed 9-13-10; 8:45 am]
BILLING CODE 7590-01-P